Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from ADA’s four scholarly journals: Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5–6 recently published articles. Intended for the busy health care professional who has little time to review journal articles in depth, Diabetes Core Update discusses how the latest research and information published in ADA journals are relevant to clinical practice and can be applied in a treatment setting.
Diabetes Core Update podcasts are free and can be accessed through iTunes or RSS feed. For more information about RSS feeds, see ADA Journals RSS Feeds. The podcasts are also accessible for listening on your computer or mobile device and can be downloaded below.
Latest Podcasts |
|
|
Diabetes Core Update December 2019 Post Date: November 26, 2019 |
Discussed in This EpisodeResidual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007–2014. Fan et al. Diabetes Care 2019 Dec; 42(12): 2307-2314. https://doi.org/10.2337/dc19-0501 Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results From Three Large Prospective U.S. Cohorts of Women and Men. Drouin-Chartier et al. Diabetes Care 2019 Dec; 42(12): 2181-2189. https://doi.org/10.2337/dc19-0734 Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study. Critchley et al. Diabetes Care 2019 Dec; 42(12): 2237-2246. https://doi.org/10.2337/dc19-0848 Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial. Rodbard et al. Diabetes Care 2019 Dec; 42(12): 2272-2281. https://doi.org/10.2337/dc19-0898 A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal‐bolus insulin or a glucagon‐like peptide‐1 receptor agonist plus basal insulin: The SIMPLE study. Abreu et al. Diabetes, Obesity and Metabolism 2019. Published Online May 30, 2019. https://doi.org/10.1111/dom.13794 |
|
Diabetes Core Update November 2019 Post Date: October 30, 2019 |
Discussed in This EpisodeNationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors. Lee et al. Diabetes Care 2019 Nov; 42(11): 2057-2064. https://doi.org/10.2337/dc18-2195 Long-term Effects of Disasters on Seniors With Diabetes: Evidence From Hurricanes Katrina and Rita. Quast et al. Diabetes Care 2019 Nov; 42(11): 2090-2097. https://doi.org/10.2337/dc19-0567 Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Wexler et al. Diabetes Care 2019 Nov; 42(11): 2098-2107.https://doi.org/10.2337/dc19-0901 Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. Blonde et al. Diabetes Care 2019 Nov; 42(11): 2108-2116.https://doi.org/10.2337/dc19-1357 Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. Husain et al. N Engl J Med 2019. Published Online August 29, 2019. https://doi.org/10.1056/NEJMoa1901118 Sodium‐glucose co‐transporter inhibitors: Medications that mimic fasting for cardiovascular prevention Giaccari et al. Diabetes, Obesity and Metabolism 2019. Published Online June 17, 2019. https://doi.org/10.1111/dom.13814 |
|
Diabetes Core Update October 2019 Post Date: September 24, 2019 |
Discussed in This EpisodeIncidence of Type 2 Diabetes in People With a History of Hospitalization for Major Mental Illness in Scotland, 2001–2015: A Retrospective Cohort Study. Jackson et al. Diabetes Care 2019 Oct; 42(10): 1879-1885. https://doi.org/10.2337/dc18-2152 Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. Sardu et al. Diabetes Care 2019 Oct. Diabetes Care 2019 Oct; 42(10): 1946-1955. https://doi.org/10.2337/dc18-2356 Change in Cardiovascular Health and Incident Type 2 Diabetes and Impaired Fasting Glucose: The Whitehall II Study. Climie et al. Diabetes Care 2019 Oct; 42(10): 1981-1987. https://doi.org/10.2337/dc19-0379 Prospective Association Among Diabetes Diagnosis, HbA1c, Glycemia, and Frailty Trajectories in an Elderly Population. Aguayo et al. Diabetes Care 2019 Oct; 42(10): 1903-1911. https://doi.org/10.2337/dc19-0497 Nasal Glucagon: A Promising New Way to Treat Severe Hypoglycemia. Lynn H. Nguyen and John R. White Jr. Clinical Diabetes 2019 Jul; 37(3): 292-293. https://doi.org/10.2337/cd19-0013 Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice. Blonde et al. Diabetes Spectrum 2019 May; 32(2): 93-103. https://doi.org/10.2337/ds17-0082 |
|
Diabetes Core Update September 2019 Post Date: August 24, 2019 |
Discussed in This EpisodeThe Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes, and Prediabetes. Dall et al. Diabetes Care 2019 Apr.; 42(4):1661-1668. https://doi.org/10.2337/dc18-1226 Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction. Tromp et al. Diabetes Care 2019 Sep; 42(9):1792-1799. https://doi.org/10.2337/dc18-2515 Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes. Guo et al. Diabetes Care 2019 Sep; 42(9): 1692-1699. https://doi.org/10.2337/dc19-0480 Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. The RISE Consortium. Diabetes Care 2019 Sep; 42(9): 1742-1751. https://doi.org/10.2337/dc19-0556 Lifestyle Counseling and Long-term Clinical Outcomes in Patients With Diabetes. Zhang et al. Diabetes Care 2019 Sep; 42(9): 1833-1836. https://doi.org/10.2337/dc19-0629 PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Aroda et al. Diabetes Care 2019 Sep; 42(9): 1724-1732. https://doi.org/10.2337/dc19-0749 |
|
Diabetes Core Update August 2019 Post Date: July 24, 2019 |
Discussed in This EpisodeDapagliflozin Plus Saxagliptin Add-on Therapy Compared with Insulin in Patients with Type 2 Diabetes Poorly Controlled by Metformin with or without Sulfonylurea Therapy: A Randomized Clinical Trial. Vilsboll et al. Diabetes Care 2019 Aug; 42(8):1464-1472. https://doi.org/10.2337/dc18-1988 Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial. Basterra-Gortari et al. Diabetes Care 2019 Aug; 42(8):1390-1397. https://doi.org/10.2337/dc18-2475 Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Bril et al. Diabetes Care 2019 Aug; 42(8): 1481-1488. https://doi.org/10.2337/dc19-0167 Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. Aroda et al. Lancet 2019. Published Online June 9, 2019. https://doi.org/10.1016/S2213-8587(19)30184-6 Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Gerstein et al. Lancet Diabetes Endocrinol 2019. Published Online June 10, 2019. https://doi.org/10.1016/S0140-6736(19)31149-3 Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Partley et al. Lancet 2019. Published June 08, 2019. https://doi.org/10.1016/S0140-6736(19)31271-1 |
|
Diabetes Core Update July 2019 Post Date: June 19, 2019 |
Discussed in This EpisodeEffect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. Yaronet et al. Diabetes Care 2019 Jul; 42 (7): 1178-1184. https://doi.org/10.2337/dc18-0166 Glucose Variations During Driving in People With Type 1 Diabetes Using a Continuous Glucose Monitoring System. Schmied and Zulewski. Diabetes Care 2019 Jul; 42 (7): 1340-1343. https://doi.org/10.2337/dc18-0822 Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Elliott et al. Diabetes Care 2019 Jul; 42 (7): 1290-1296. https://doi.org/10.2337/dc18-2266 Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial. Bode et al. Diabetes Care 2019 Jul; 42 (7): 1255-1262. https://doi.org/10.2337/dc19-0009 Association of Self-Reported Sleep and Circadian Measures With Glycemia in Adults With Prediabetes or Recently Diagnosed Untreated Type 2 Diabetes. Mokhlesi et al., for the RISE Consortium. Diabetes Care 2019 Jul; 42 (7): 1326-1332. https://doi.org/10.2337/dc19-0298 Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Bersoff-Matcha et al. Ann Intern Med. 2019;170(11):764-769. https://doi.org/10.7326/M19-0085 |
|
Diabetes Core Update June 2019 Post Date: May 24, 2019 |
Discussed in This EpisodeBiochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes. Patel et al. Diabetes Care 2019 Jun; 42 (6): 1132-1135. https://doi.org/10.2337/dc18-1453 Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control. Munshi et al. Diabetes Care 2019 Jun; 42 (6): 1129-1131. https://doi.org/10.2337/dc18-1631 Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts. Andersen et al. Diabetes Care 2019 Jun; 42 (6): 1095-1103. https://doi.org/10.2337/dc18-2158 Open AccessInternational Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors. Danne et al. Diabetes Care 2019 Jun; 42 (6): 1147-1154. https://doi.org/10.2337/dc18-2316 Diabetes Care Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Riddle et al. Diabetes Care 2019 Jun; 42 (6): 1136-1146. https://doi.org/10.2337/dci19-0020 When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control. Umpierrez et al. Diabetes, Obesity and Metabolism 2019 Feb. https://onlinelibrary.wiley.com/doi/full/10.1111/dom.13653 |
|
►Diabetes Core Update May 2019 Post Date: April 26, 2019 |
Discussed in This EpisodeEffect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Salas-Salvadó et al. for the PREDIMED-Plus investigators. Diabetes Care 2019 May; 42(5): 777-788. https://doi.org/10.2337/dc18-0836 Randomized Trial of a Tailored Cognitive Behavioral Intervention in Type 2 Diabetes with Comorbid Depressive and/or Distress Symptoms—Twelve-Month Outcomes from COMRADE (Abstract). Cummings et al. Diabetes 2018 Jul; 67(Supplement 1). https://doi.org/10.2337/db18-867-P Early Intervention for Diabetes in Medical and Surgical Inpatients Decreases Hyperglycemia and Hospital-Acquired Infections: A Cluster Randomized Trial. Kyi et al. Diabetes Care 2019 May; 42(5): 832-840. https://doi.org/10.2337/dc18-2342 Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Evert et al. Diabetes Care 2019 May; 42(5): 731-754. https://doi.org/10.2337/dci19-0014 Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials. Zelniker et al. Circulation. 2019;139:2022–2031. https://doi.org/10.1161/CIRCULATIONAHA.118.038868 When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control. Umpierrez et al. Diabetes, Obesity and Metabolism 2019. https://doi.org/10.1111/dom.13653 (Epub at https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13653.) |
|
►Diabetes Core Update April 2019 Post Date: March 26, 2019 |
Discussed in This EpisodeEarly Detection of Hypoglycemia in Type 1 Diabetes Using Heart Rate Variability Measured by a Wearable Device. Bekkink et al. Diabetes Care https://doi.org/10.2337/dc18-1843 |
|
►Diabetes Core Update March 2019 Post Date: February 25, 2019 |
Discussed in This EpisodeThe legacy effect in type 2 diabetes: Impact of early glycemic control on future complications (The Diabetes & Aging Study). Diabetes Care https://doi.org/10.2337/dc17-1144 Eye care utilization among insured people with diabetes in the U.S. 2010-2014. Diabetes Care https://doi.org/10.2337/dc18-0828 Hyperglycemia & Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Maternal gestational diabetes and childhood glucose metabolism. Diabetes Care https://doi.org/10.2337/dc18-1646 A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care https://doi.org/10.2337/dc18-1760 Oral semaglutide. Clinical Diabetes https://doi.org/10.2337/cd18-0034 Patient commitment and its relationship to A1C. Clinical Diabetes https://doi.org/10.2337/cd18-0003 |
|
►Diabetes Core Update February 2019 Post Date: January 24, 2019 |
Topics Covered in this EditionParticipating in mental, social and physical leisure activities and having a rich social network reduces the incidence of diabetes-related dementia in a cohort of Swedish older adults. https://doi.org/10.2337/dc18-1428 Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, including Dapagliflozin, is Consistent Across the Class: an Analysis of the Placebo Arm of EXSCEL http://doi.org/10.2337/dc18-1871 Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease https://doi.org/10.2337/dbi18-0007 Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study https://doi.org/10.1136/bmj.k3359 Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study https://doi.org/10.1136/bmj.k2693 Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus https://doi.org/10.1056/NEJMoa1804989 |
|
►Diabetes Core Update January 2019 Post Date: December 26, 2018 |
Topics Covered in this EditionLinagliptin Cardiovascular Outcome Trial (CARMELINA) |
|
►Diabetes Core Update December 2018 Post Date: December 1, 2018 |
Articles Covered in this EditionAn Automated Grading System for Vision-Threatening Referable Diabetic Retinopathy Detection based on Color Fundus Photographs http://doi.org/10.2337/dc18-0147 Evaluation and management of youth-onset type 2 diabetes: A statement of the American Diabetes Association http://doi.org/10.2337/dci18-0052 Older Adults and Diabetes Prevention Programs in the Veterans Health Administration http://doi.org/10.2337/dc18-1141 Impact of Gastric Banding versus Metformin on β-Cell Function in Adults with Impaired Glucose Tolerance or Mild Type 2 Diabetes http://doi.org/10.2337/dc18-1662 Paternal Exercise Improves Glucose Metabolism in Adult Offspring http://doi.org/10.2337/db18-0667 Glucagon-Like Peptide-1 Increases Beta Cell Regeneration by Promoting Alpha- to Beta-Cell Transdifferentiation http://doi.org/10.2337/db18-0155 |
|
►Diabetes Core Update November 2018 Post Date: November 1, 2018 |
Articles Covered in this EditionTrends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988–2015 |
|
►Diabetes Core Update October 2018 Post Date: October 1, 2018 |
Articles Covered in this EditionLong-term relapse of type 2 diabetes after Roux-en-Y gastric bypass: prediction and clinical relevance Time to treatment intensification and its association with subsequent glycemic control among 93,515 patients with type 2 diabetes following monotherapy failure. Glycaemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study More similarities than differences testing insulin glargine 300 U/mL versus insulin degludec 100 U/mL in insulin-naïve type 2 diabetes: The randomized head-to-head BRIGHT trial Glycemic Variation and Cardiovascular Risk in the Veteran's Affairs Diabetes Trial LDL-cholesterol rises with body mass index only in lean individuals: cross-sectional US and Spanish representative data |
|
►Diabetes Core Update Sep 2018 Post Date: Aug 25, 2018 |
Articles Covered in this EditionA 26-week, randomized, controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes (The DEPICT-2 study): 24-Week Results from a Randomized Controlled Trial Sotagliflozin in Combination with Optimized Insulin Therapy in Adults with Type 1 Diabetes: The North American inTandem1 Study Poor Glycemic Control is Associated with Increased Extracellular Volume Fraction in Diabetes |
|
►Diabetes Core Update Aug 2018 Post Date: July 25, 2018 |
Articles Covered in this EditionA Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride |
|
►Diabetes Core Update July 2018 Post Date: June 25, 2018 |
Articles Covered in this EditionHealth Care Spending on Diabetes in the U.S., 1996–2013 Diabetes-Attributable Nursing Home Costs for Each U.S. State Risk of Type 2 Diabetes Among Lesbian, Bisexual, and Heterosexual Women: Findings From the Nurses’ Health Study II Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications Freestyle Libre Glucose Monitoring System |
|
►Diabetes Core Update June 2018 Post Date: May 24, 2018 |
Articles Covered in this EditionInfluence of Diabetes on Trends in Perioperative Cardiovascular Events The Presence of Diabetes and Higher HbA1c Are Independently Associated With Adverse Outcomes After Surgery Postoperative Death After Lower-Limb Amputation in a National Prevalent Cohort of Patients With Diabetes Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks Insulin Access and Affordability Working Group: Conclusions and Recommendations |
|
►Diabetes Core Update May 2018 Post Date: April 24, 2018 |
Articles Covered in this EditionEfficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial Magnitude and Pattern of Placebo Response in Clinical Trials of Oral Antihyperglycemic Agents: Data From the U.S. Food and Drug Administration, 1999–2015 Prevalence of Major Behavioral Risk Factors for Type 2 Diabetes Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark Obesity Progression Between Young Adulthood and Midlife and Incident Diabetes: A Retrospective Cohort Study of U.S. Adults Economic Costs of Diabetes in the U.S. in 2017 |
|
►Diabetes Core Update April 2018 Post Date: April 4, 2018 |
Articles Covered in this EditionClinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women’s Health Initiative Dietary Modification Trial Long-term Diet Quality and Risk of Type 2 Diabetes Among Urban Chinese Adults The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study |
|
►Diabetes Core Update March 2018 Post Date: February 26, 2018 |
Articles Covered in this EditionEffect of Changing Work Stressors and Coping Resources on the Risk of Type 2 Diabetes: The OHSPIW Cohort Study Objectively Measured Physical Activity and Sedentary Time Are Associated With Cardiometabolic Risk Factors in Adults With Prediabetes: The PREVIEW Study Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study |
|
►Diabetes Core Update February 2018 Post Date: January 30, 2018 |
Articles Covered in this EditionIncretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial Increased Liver Fatty Acid Uptake Is Partly Reversed and Liver Fat Content Normalized After Bariatric Surgery How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial |
|
►Diabetes Core Update January 2018 Post Date: December 28, 2017 |
Articles Covered in this EditionThe Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum |
|
Diabetes Core Update December 2017 Post Date: November 28, 2017 |
Articles Covered in this EditionIncidence and Trends in Hypoglycemia Hospitalization in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study Time Trends of Dietary and Lifestyle Factors and Their Potential Impact on Diabetes Burden in China Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP International Consensus on Use of Continuous Glucose Monitoring Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: Why Weight Loss Maintenance Is Difficult |
|
Diabetes Core Update November 2017 Post Date: October 24, 2017 |
Articles Covered in this EditionElevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes The Role of Hyperglycemia, Insulin Resistance, and Blood Pressure in Diabetes-Associated Differences in Cognitive Performance—The Maastricht Study Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events |
|
Diabetes Core Update October 2017 Post Date: October 4, 2017 |
Articles Covered in this EditionLow-Dose Persistent Organic Pollutants Impair Insulin Secretory Function of Pancreatic β-Cells: Human and In Vitro Evidence Genetic Susceptibility, Change in Physical Activity, and Long-term Weight Gain A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016 |
|
Special Edition: Diabetes Is Primary 2017 Part 2 Post Date: September 13, 2017 |
Special EditionDiabetes Is Primary 2017 Find complete versions of the Diabetes Is Primary lectures and earn CE credit for free online at https://ada.healthmonix.com/. |
|
Diabetes Core Update September 2017 Post Date: August 29, 2017 |
Articles Covered in this EditionComputed Tomography Angiography Images of Coronary Artery Stenosis Provide a Better Prediction of Risk Than Traditional Risk Factors in Asymptomatic Individuals With Type 2 Diabetes: A Long-term Study of Clinical Outcomes Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes A Team-Based Online Game Improves Blood Glucose Control in Veterans With Type 2 Diabetes: A Randomized Controlled Trial Diabetes and Hypertension: A Position Statement by the American Diabetes Association DASH Eating Plan: An Eating Pattern for Diabetes Management Ways Health Care Providers Can Promote Better Medication Adherence |
|
Special Edition: Diabetes Is Primary 2017 Part 1 Post Date: August 15, 2017 |
Special EditionDiabetes Is Primary 2017 Find complete versions of the Diabetes Is Primary lectures and earn CE credit for free online at https://ada.healthmonix.com/. |
|
Diabetes Core Update August 2017 Post Date: July 26, 2017 |
Articles Covered in this EditionMaternal Exercise Improves Glucose Tolerance in Female Offspring An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record–Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes Mediterranean Eating Pattern Presented at ADA's Scientific Sessions: Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial |
Access Podcast Archive
Return to Latest Podcasts
To cite information from a podcast, use the following format: "Author name(s): Article title (article DOI). Podcast Series Name [podcast], day month year available. Speaker name(s) (host). URL from which Podcast was retrieved"
For example, Yeh H.-C., et al.: A prospective study of the associations between treated diabetes and cancer outcomes (doi:10.2337/dc11-0225). Diabetes Core Update [podcast], 6 March 2012. Skolnik N, Russel J (hosts). Podcast retrieved from http://www.diabetesjournals.org/content/diabetes-core-update-podcasts